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Female sex and cardiovascular disease risk
in rural Uganda: a cross-sectional,
population-based study
Itai M. Magodoro1,2* , Maggie Feng2, Crystal M. North1,2, Dagmar Vořechovská2, John D. Kraemer3,
Bernard Kakuhikire4, David Bangsberg5, Alexander C. Tsai1,2 and Mark J. Siedner1,2,4,6
Abstract
Background: Sex-based differences in cardiovascular disease (CVD) burden are widely acknowledged, with male
sex considered a risk factor in high-income settings. However, these relationships have not been examined in sub-
Saharan Africa (SSA). We aimed to apply the American Heart Association (AHA) ideal cardiovascular health (CVH)
tool modified by the addition of C-reactive protein (CRP) to examine potential sex-based differences in the
prevalence of CVD risk in rural Uganda.
Methods: In a cross-sectional study nested within a population-wide census, 857 community-living adults
completed physical and laboratory-based assessments to calculate individual ideal CVH metrics including an eight
category for CRP levels. We summarized sex-specific ideal CVH indices, fitting ordinal logistic regression models to
identify correlates of improving CVH. As secondary outcomes, we assessed subscales of ideal CVH behaviours and
factors. Models included inverse probability of sampling weights to determine population-level estimates.
Results: The weighted-population mean age was 39.2 (1.2) years with 52.0 (3.7) % females. Women had ideal
scores in smoking (80.4% vs. 68.0%; p < 0.001) and dietary intake (26.7% vs. 16.8%; p = 0.037) versus men, but the
opposite in body mass index (47.3% vs. 84.4%; p < 0.001), glycated hemoglobin (87.4% vs. 95.2%; p = 0.001), total
cholesterol (80.2% vs. 85.0%; p = 0.039) and CRP (30.8% vs. 49.7%; p = 0.009). Overall, significantly more men than
women were classified as having optimal cardiovascular health (6–8 metrics attaining ideal level) (39.7% vs. 29.0%;
p = 0.025). In adjusted models, female sex was correlated with lower CVH health factors sub-scales but higher ideal
CVH behaviors.
Conclusions: Contrary to findings in much of the world, female sex in rural SSA is associated with worse ideal CVH
profiles, despite women having better indices for ideal CVH behaviors. Future work should assess the potential role
of socio-behavioural sex-specific risk factors for ideal CVH in SSA, and better define the downstream consequences
of these differences.
Keywords: Ideal cardiovascular health, Cardiovascular disease, Population health, Sex differences, Uganda, Sub-
Saharan Africa
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Background
The exacting human cost imposed by cardiovascular dis-
eases (CVDs) in both high and low-income settings has
motivated innovative strategies to mitigate their impact.
In 2010, the American Heart Association (AHA) [1] in-
troduced the concept of “ideal cardiovascular health
(ideal CVH)” in order to meet the urgent need for pre-
venting cardiovascular morbidity and mortality. Ideal
CVH is based on 7 metrics: smoking status, dietary in-
take, physical activity, body mass index (BMI), blood
pressure (BP), total cholesterol (TC), and fasting blood
glucose. When present at ideal levels, increasing fre-
quency of these metrics is mirrored in proportionate de-
creases in risk of major adverse cardiovascular events
(MACE) [2, 3].
Sex is a well-described independent risk factor for
CVD [4, 5] with male sex considered a risk marker for
incident atherosclerotic CVD in high-income settings
[6]. This increased risk arises from both biological and
sociocultural differences between men and women [7].
Sex as a biological variable underlies physiological
variation in vascular function, coagulation, fibrinolysis
and energy metabolism, among others [8, 9]. Gender
also contributes to CVD risk through differences in
social roles, environmental exposures, health seeking
behaviors, and access to resources including medical
care [4, 10, 11].
Whether and how these relationships between sex and
gender and CVDs apply in sub-Saharan Africa (SSA) is
not well known, despite the rapidly increasing burden of
CVD in the region [12, 13]. Limited available evidence,
however, indicates that women in SSA have a higher
age-standardized CVD mortality rate than their male
counterparts, and that this is substantially higher than
the corresponding rates for both men and women in
high-income countries [14]. Thus, an understanding of
the role of sex and gender is critically important to cur-
tail the human costs of CVDs and improve CVH in SSA.
To help build the evidence base to support the formu-
lation of data-driven health policies in SSA, we aimed to
define the AHA’s ideal CVH construct in a
community-based, general population in rural Uganda.
We hypothesized that the population distribution of
ideal CVH metrics and indices would demonstrate lower
rates of ideal CVH profiles than described elsewhere,
and that these would differ between men and women.
Methods
Study population and setting
We conducted a cross-sectional study to describe AHA
ideal CVH metrics in southwestern Uganda. Participants
were community-dwelling adults, residing in Nyakabare
Parish, Mbarara District, who attended one of five vol-
untary health fairs in June 2015. The parish is
characterized by a subsistence pastoral-agrarian econ-
omy in which both food and water insecurity are com-
mon [15]. It is also the location of an ongoing
longitudinal study that conducted a census in 2014 and
collected data on 98% of all adults (1814/1851) residing
there. Participation in the health fair study was limited
to participants in the parent census study. Recruitment
was enriched through radio advertisements and an-
nouncements at social and religious gatherings. The in-
stitutional review boards of Mbarara University of
Science and Technology, Uganda, and Partners Health-
care, Boston, approved the protocol, and all study partic-
ipants gave written informed consent. Consistent with
national guidelines, we also obtained clearance for the
study from the Ugandan National Council of Science
and Technology and from the Research Secretariat in
the Office of the President.
Data collection
Surveys were administered to elicit age; sex; educational
attainment; medical history; and active medication use
for hypertension, dyslipidemia, heart failure, asthma or
diabetes mellitus. We assessed socioeconomic status
using household-owned assets and housing characteris-
tics aggregated into an asset wealth index and divided in
tertiles [16]. Questionnaires based on the International
Physical Activity Questionnaire (IPAQ) [17] and the
WHO STEPS instrument [18] were administered to col-
lect data on physical activity, tobacco use, and fruit and
vegetable intake. Physical activity was measured as meta-
bolic equivalent of task (MET) in minutes per week [17].
We also measured height, weight, and BP. BP was
measured in a seated position using automated sphyg-
momanometers (Omron HEM 705 LP, Omron Health-
care, Inc., Bannockburn, IL). Venous blood was collected
to assess serum lipids, C-reactive protein (CRP), and
performed at Epicentre Research Base in Mbarara,
Uganda using a Cobas c111 (Roche, Basel, Switzerland)
serum chemistry analyser and point-of-care glycated
haemoglobin (HbA1c) (Siemens DCA Vantage, Munich,
Germany).
AHA cardiovascular health metrics
We categorized each of the seven CVH metrics defined
by the AHA as poor, intermediate, or ideal based on
published guidelines [1]. For our primary analyses, we
added CRP as an additional metric, due to its strong cor-
relation with CVD risk in multiple populations [19],
allowing for a total of eight categories in our ideal CVH
metrics score (Table 1). We also assigned two AHA
sub-categories of ideal CVH, based on AHA recommen-
dations, as: (1) five ideal CVH factors, which included
BP, TC, HbA1c, CRP and BMI; and (2) three ideal CVH
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Table 1 Definitions of American Heart Association Individual Ideal Cardiovascular Health Metrics
Metric Definition
AHA Criteria Criteria in present study
Total cholesterol (TC) No adjustment
Ideal TC < 200mg/dL without use of any
cholesterol-lowering medication
Intermediate TC 200–239mg/dL or
treated to < 200mg/dL
Poor TC ≥240mg/dL
Blood pressure No adjustment
Ideal BP < 120/< 80mmHg without use of
antihypertensive medications
Intermediate Systolic BP 120–139 or
diastolic BP 80–89 mmHg or
treated to BP < 120/< 80mmHg
Poor BP ≥140/≥90mmHg
Fasting plasma glucose Glycated hemoglobin
Ideal < 100mg/dL HbA1c < 5.7% and without any
hypoglycemic medication
Intermediate 100–125mg/dL HbA1c 5.7–6.4% or
treated to HbA1c < 5.7%
Poor ≥126mg/dl HbA1c ≥6.5%
Body mass index (BMI) No adjustment
Ideal BMI < 25 kg/m2
Intermediate BMI 25–29.9 kg/m2
Poor BMI ≥30 kg/m2
Diet No adjustment
Ideal 4–5 components ≥20 servings/week
Intermediate 2–3 components
Poor 0–1 components < 20 servings/week
Physical activity No adjustment
Ideal ≥150min/week moderate intensity or
≥75min/week vigorous intensity or
≥150min/week moderate + vigorous
≥1500METmin/week
Intermediate 1–149min/week moderate intensity or
1–74 min/week vigorous intensity or
1–149min/week moderate + vigorous
600-1500METmin/week
Poor None <600METmin/week
Smoking No adjustment
Ideal Never or quit > 12 months Never having smoked or
quit > 12 months prior
Intermediate Former ≤12 months Quit within the preceding
1–12 months
Poor Current Current smoking status or
quit within the preceding 1 month.
C-reactive protein (CRP) None
Ideal CRP < 1.0 mg/dL
Intermediate CRP 1-3 mg/dL
Poor CRP ≥3 mg/dL
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behaviors, which included diet, physical activity, and
smoking.
Ideal CVH health factors and health behaviors
We characterized the CVH metrics as poor, intermedi-
ate, or ideal as indicated in Table 1. In place of plasma
fasting glucose in the standard AHA score, we measured
HbA1c, and selected the three categories based on inter-
national consensus [20] HbA1c thresholds of < 5.7%,
5.7–6.4% and ≥ 6.5%, respectively, as cut-offs for normal,
pre-diabetic, and diabetic states. CRP was categorized as
ideal (< 1.0 mg/dL), intermediate (1-3 mg/dL), and poor
(≥3mg/dL) corresponding to standard definitions of
CRP and CVD risk [21]. Complete data were available
for only one of the five AHA components used to score
the diet metric. We therefore used fruit and vegetable
intake to define ideal (≥20 servings/week) and non-ideal
(< 20 servings/week) diet as previously described [22].
Physical activity was converted to metabolic equivalents
of task (METs) in minutes, and categorized as ≥1500
MET min/week for ideal, 600–1500 MET min/week for
intermediate, and < 600 MET min/week for poor phys-
ical activity [17].
Data analysis
We used inverse probability of health fair attendance
sampling weights to estimate population-representative
descriptive statistics, cardiovascular health metrics, and
regression models. To do so, we first estimated the prob-
ability of attending the health fair, conditional on partici-
pants` characteristics from the community census. This
value was calculated by fitting logistic regression models
with the entire census dataset, with health fair attend-
ance as the outcome of interest and adjusted for 16 vari-
ables predicted to correlate with health fair attendance
(See Additional file 1: Methods). This regression
assigned a conditional probability weight of health fair
attendance for each individual attending the health fair.
The inverse of the predicted conditional probabilities of
health fair attendance were then applied as stabilized in-
verse probability of treatment weights (IPTW) using
methods described previously by Hernan et al. [23]. We
assessed the validity of this method by comparing popu-
lation characteristics as estimated by our IPTW models
with variables in the census that were not included in
the IPTW model (Additional file 1: Table S3).
We next summarized the weighted population dataset,
applying stabilized IPTW weights, to obtain population-
level characteristics and proportions assigned to each
cardiovascular health index. Continuous variables were
described by means and standard errors (SEs), and com-
parisons between groups were made using t-tests or cor-
responding nonparametric tests after assessing
distributional properties. Categorical variables were
described by percentages and compared by chi-squared
tests.
Our primary outcome of interest was AHA ideal CVH
metric score, which was categorized as an integer value
ranging from 0 to 8 where participants received one
point per criterion met for ideal health. As secondary
outcomes of interest, we assessed ideal CVH behaviors
as a score of 0–3 and ideal CVH factors as a score of 0–
5. Our primary exposure of interest was sex. Secondary
exposures of interest were age, categorized as 18–39;
40–59; and ≥ 60 years, wealth, categorized as tertiles of
the Filmer-Pritchett asset index, and educational attain-
ment. “Education was categorized as none”, “some pri-
mary education”, “completed primary education” and
“post-primary education”.
We examined the distribution of each of the CVH
metrics according to CVH status (poor, intermediate
and ideal) stratified by sex and age. The numbers of
health factors and health behaviors at the ideal level
were also examined and graphically depicted by age and
sex strata. Finally, we then fit univariable and multivari-
able ordinal logistic regression models to estimate ad-
justed associations between sex and indices of ideal
cardiovascular health, ideal health behaviors and ideal
health factors; and estimated the mean predicted prob-
abilities of ideal CVH behaviors and factors by age and
sex using post-estimation margins [24]. All statistical
analyses were performed using Stata software (version
14.0, StataCorp, College Station, TX) with a two-sided
P-value < 0.05 considered statistically significant.
Results
Demographic characteristics
A total of 857 individuals attended a health fair out of
1814 (47%) cohort participants. Analyses were confined
to 756 (42%) participants with complete data to calculate
all 7 AHA CVH metrics plus CRP. Compared to
non-attendees, health fair attendees were older (p <
0.001), more likely to be female (p < 0.001), with less for-
mal educational attainment (p < 0.001). Notably, at-
tendees were twice as likely as non-attendees to report
very bad or bad health (1.4% vs. 0.7, and 26.5% vs.
13.1%, respectively, p < 0.001) (Additional file 1: Table
S4). There were no significant differences in cardiovas-
cular risk characteristics between health fair attendees
who were included or excluded from the analysis due to
missing data (Additional file 1: Table S5).
The weighted study population mean age was 39.2
years (1.2), (Table 2). The population was 52.0% female,
and 4.1 and 3.3%, respectively, had a history of heart fail-
ure or stroke. Compared to men, women were signifi-
cantly older (41.5 vs. 36.8 years; p = 0.016), were less
likely to have formal education (none: 20.1% vs. 5.2%),
were more likely to be poor (44.2% vs. 29.1%), and had a
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higher BMI (mean BMI 26.0 vs. 22.4 kg/m2; p < 0.001).
Three times as many women as men self-reported heart
failure history (6.3% vs. 1.8%: p = 0.012).
Cardiovascular health indices
The distribution of individual CVH metrics in the total
population, and stratified by age and sex, are shown in
Additional file 1: Table S1 and Fig. 1. Figures 2 and 3 de-
pict the distribution of the number of ideal components
of cardiovascular health, behaviors and factors by sex.
Overall, only 3.2% of the weighted population had all 7
AHA metrics and CRP at ideal CVH levels. Though
more women than men had all 8 metrics (CRP plus 7
AHA) at the ideal level (4.4% vs. 1.8%; p = 0.018), men
had a higher number of metrics at ideal level out of 8
(5.1 vs. 4.7; p = 0.010) and higher proportion with at
least 6 ideal CVH metrics (39.7% vs. 29.0%; p = 0.025)
(Additional file 1: Table S2).
Men and women tended to have similar levels of ideal
CVH categories for BP and physical activity (Fig. 1).
However, men had a higher frequency of BMI, TC,
HbA1c and CRP achieving ideal health status than the
women. Overall, men had better CVH factor profiles (5
out of 5 metrics at ideal level) than women (16.3% vs.
9.4%; p < 0.001). However, women had the more favor-
able CVH behaviors profile (3 out of 3 metrics at ideal
level) (8.8% vs. 20.4%; p = 0.027) (Figs. 2 and 3).
In univariable models, female sex was associated with
worsening CVH status (OR 0.59; 95% CI: 0.40–0.87; p =
0.008) (Table 3). After adjusting for age, asset wealth and
education, female sex remained correlated with worse
CVH metrics, although this did not achieve statistical
significance (adjusted OR 0.70; 95%CI: 0.47–1.03). Inter-
estingly, women were more likely than men to be classi-
fied into higher categories of ideal CVH behaviors
(adjusted OR 2.87; 95% CI: 1.72–4.78; p < 0.001), but less
Table 2 Baseline characteristics of weighted population
Weighted population estimate, mean (SE) or proportion (%) (SE)
Female Male P valuea Total
Sex (%) 52.0 (3.7) 48.0 (3.7) 0.656 –
Age, mean (years) 41.5 (1.1) 36.8 (1.7) 0.016 39.2 (1.0)
Age group (years) (%)
16–39 54.1 (3.0) 66.0 (4.3) 59.9 (2.8)
40–64 30.6 (2.6) 23.1 (3.3) 26.9 (2.2)
≥ 65 15.3 (1.9) 10.9 (2.0) 0.042 13.2 (1.4)
BMI (kg/m2) 26.0 (0.3) 22.4 (0.2) < 0.001 24.3 (0.2)
Formal educational attainment (%)
None 20.1 (2.0) 5.2 (1.3) 12.8 (1.3)
Some primary education 30.4 (2.5) 20.8 (3.1) 25.7 (2.1)
Completed primary education 21.8 (2.3) 24.4 (4.2) 23.1 (2.3)
Post-primary education 27.7 (3.4) 49.5 (5.7) < 0.001 38.4 (3.6)
Filmer-Pritchett asset index (%)
Poor 44.2 (2.9) 29.1 (4.2) 36.7 (2.7)
Middle 18.2 (2.0) 25.6 (6.1) 21.8 (3.2)
Rich 37.6 (3.1) 45.3 (5.7) 0.047 41.5 (3.2)
History of heart failure (%) 6.3 (1.1) 1.8 (0.1) 0.012 4.1 (0.7)
History of stroke (%) 1.8 (0.5) 4.8 (2.3) 0.078 3.3 (1.2)
Current hypertension (%)b 12.3 (1.8) 8.8 (1.8) 0.204 10.6 (1.4)
Systolic BP (mmHg) 123.7 (1.4) 124.5 (1.4) 0.564 124.0 (1.0)
Diastolic BP (mmHg) 80.1 (0.8) 76.7 (1.3) 0.024 78.5 (0.8)
Current diabetes mellitusc 2.2 (0.7) 1.6 (0.7) 0.546 2.0 (0.5)
HbA1c (%) 5.3 (0.04) 5.1 (0.03) > 0.001 5.2 (0.03)
Total cholesterol (mg/dL) 167.0 (2.4) 155.7 (5.2) 0.049 161.5 (2.8)
Current use of chronic medication (%) 6.2 (1.2) 2.9 (0.1) 0.037 4.6 (0.8)
aBoldface indicates statistical significance (p < 0.05)
bSelf-reported hypertension and/or blood pressure ≥ 140/90 mmHg at screening
cSelf-reported diabetes mellitus and/or HbA1c ≥6.5%
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likely to be classified into higher categories of ideal CVH
factors (adjusted OR 0.32; 95% CI: 0.21–0.49; p < 0.001)
(Tables 4 and 5). In all models, increasing age was sig-
nificantly associated with having fewer CVH metrics
and factors. In both adjusted and unadjusted models,
having some formal education, relative to no education,
was positively correlated with ideal CVH behaviors. In
contrast, relative household wealth was negatively asso-
ciated with ideal CVH metrics and ideal health factors.
Compared to the poorest quartile of asset ownership,
increasing wealth predicted worsening CVH metrics
and health factors. However, we found no apparent re-
lationship between relative household wealth and
health behaviors. The mean adjusted probabilities of
having all 3 behaviors at the ideal CVH level, if age,
wealth and educational attainment were equal to mean
for all participants, were 18.0% (95% CI: 12.8–23.2%)
for women and 7.1% (95% CI: 3.9–10.4) for men. The
corresponding adjusted probabilities of having all 5 fac-
tors attaining ideal CVH level were 5.8% (95% CI: 3.1–
8.6) for women and 16.0% (95% CI: 9.0–23.0) for men
(Tables 6 and 7).
Discussion
In this cross-sectional, population-based study in rural
Uganda, we found significant sex-based differences in
CVH metrics. Based on a modified definition of AHA
ideal CVH with 8 metrics, significantly more men than
women were classified as having optimum CVH (6–8
metrics attaining ideal level) (39.7% vs. 29.0%; p = 0.025),
while 3 times as many women as men had poor CVH
(0–2 metrics attaining ideal level) (7.8% vs. 2.9%; p =
0.025). Additionally, women had significantly worse
CVH factor profiles despite having significantly in-
creased CVH behavior profiles. These relationships
remained consistent after adjustment for age, household
wealth and educational attainment.
The sex differences in ideal CVH were unexpected,
and contrary to what has been reported in high-income
areas. For example, in the Heart SCORE study [25],
reporting on ideal CVH among community-living adults
(mean age 59 years) of mixed ethnicity/race in the USA,
women had better CVH factor profiles than men but
similar CVH behavior profiles. Similarly, in an urban
center in Northern China [26], the proportion of women
Fig. 1 Prevalence of ideal, intermediate and poor cardiovascular health for each of the seven [7] metrics and C-reactive protein among males
and females
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Fig. 2 Weighted proportion of subjects with different numbers of ideal cardiovascular health factors in the overall population according to sex
Fig. 3 Weighted proportion of subjects with different numbers of ideal cardiovascular health behaviors in the overall population according to sex
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Table 3 Association between ideal cardiovascular health metrics and demographic and socio-economic variables – ordered logistic
regression
Ideal CVH metrics
Univariate Multivariable
OR 95% CI P valuea OR 95% CI P valuea
Sex
Male 1.00 1.0
Female 0.59 0.40–0.87 0.008 0.70 0.47–1.03 0.072
Age group (years)
16–39 1.00 1.00
40–60 0.35 0.23–0.54 < 0.001 0.36 0.24–0.55 < 0.001
≥ 60 0.10 0.06–0.16 < 0.001 0.10 0.06–0.18 < 0.001
Filmer-Pritchett asset index
Poor 1.00 1.00
Middle 0.77 0.54–1.11 0.160 0.58 0.34–0.94 0.028
Rich 0.57 0.34–0.94 0.027 0.38 0.22–0.62 < 0.001
Highest educational attainment (%)
None 1.0 1.0
Some primary 2.17 1.40–3.37 0.001 1.39 0.84–2.30 0.195
Completed primary 2.95 1.81–4.80 < 0.001 1.51 0.83–2.73 0.177
Post-primary 3.40 1.97–5.88 < 0.001 1.99 1.08–3.66 0.027
a Boldface indicates statistical significance (p < 0.05)
Table 4 Association between ideal cardiovascular health factors and demographic and socio-economic variables – ordered logistic
regression
Ideal CVH Factors
Univariate Multivariable
OR 95% CI P valuea OR 95% CI P valuea
Sex
Male 1.00 1.0
Female 0.34 0.23–0.52 < 0.001 0.32 0.21–0.49 < 0.001
Age group (years)
16–39 1.00 1.00
40–60 0.42 0.28–0.63 < 0.001 0.41 0.27–0.62 < 0.001
≥ 60 0.25 0.15–0.40 < 0.001 0.21 0.13–0.35 < 0.001
Filmer-Pritchett asset index
Poor 1.00 1.00
Middle 0.61 0.41–0.91 0.014 0.47 0.26–0.86 0.015
Rich 0.44 0.26–0.75 0.003 0.31 0.18–0.53 < 0.001
Highest educational attainment (%)
None 1.0 1.0
Some primary 1.46 0.96–2.22 0.075 1.01 0.64–1.61 0.958
Completed primary 2.08 1.25–3.46 0.003 1.15 0.67–1.97 0.614
Post-primary 1.84 1.08–3.12 0.024 1.08 0.56–2.08 0.826
a Boldface indicates statistical significance (*p < 0.05)
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Table 5 Association between ideal cardiovascular health behaviors and demographic and socio-economic variables – ordered
logistic regression
Characteristic Ideal CVH Behaviors
Univariate Multivariable
OR 95% CI P valuea OR 95% CI P valuea
Sex
Male 1.00 1.0
Female 1.76 1.14–2.72 < 0.001 2.87 1.72–4.78 < 0.001
Age group (years)
16–39 1.00 1.00
40–60 0.57 0.37–0.88 0.011 0.56 0.36–0.88 0.011
≥ 60 0.12 0.07–0.21 < 0.001 0.15 0.08–0.27 < 0.001
Filmer-Pritchett asset index
Poor 1.00 1.00
Middle 1.14 0.71–1.82 0.585 1.04 0.66–1.64 0.858
Rich 1.05 0.64–1.71 0.860 0.86 0.52–1.41 0.557
Highest educational attainment (%)
None 1.0 1.0
Some primary 2.60 1.50–4.48 0.001 1.95 1.11–3.43 0.020
Completed primary 2.92 1.57–5.42 0.001 1.95 0.97–3.92 0.059
Post-primary 3.98 2.14–7.39 < 0.001 3.38 1.67–6.84 0.001
a Boldface indicates statistical significance (*p < 0.05)
Table 6 Adjusted probability of ideal cardiovascular health metrics by demographic and socio-economic characteristics
Adjusted predicted probability, % (95% CI)
Number of ideal CVH factors
≤1 2 3 4 5
Mean overall probability 6.0 (4.3–7.5) 14.9 (12.1–17.8) 41.4 (34.1–48.7) 28.3 (22.0–34.5) 9.4 (5.6–13.3)
Sex
Female 9.7 (6.7–12.7) 21.2 (16.4–26.0) 42.4 (35.9–49.0) 20.8 (14.7–26.9) 5.8 (3.1–8.6)
Male 3.4 (2.2–4.6) 9.3 (6.8–11.9) 34.6 (26.1–43.0) 36.7 (29.3–44.1) 16.0 (9.0–23.0)
Age group (years)
16–39 3.8 (2.5–5.0) 10.3 (7.8–12.8) 37.3 (28.9–45.6) 35.3 (27.8–42.9) 14.5 (8.1–20.9)
40–60 8.6 (5.7–11.5) 19.5 (14.3–24.7) 42.5 (35.8–49.3) 22.7 (16.7–28.8) 6.6 (3.7–9.6)
≥ 60 15.7 (9.1–22.3) 28.0 (21.4–34.5) 39.0 (32.1–46.0) 13.9 (7.8–19.9) 3.5 (1.4–5.6)
Filmer-Pritchett asset index
Poor 3.1 (1.9–4.3) 8.6 (5.9–11.3) 33.3 (25.9–40.6) 37.7 (30.4–45.0) 17.3 (10.6–23.9)
Middle 6.4 (2.8–9.9) 15.7 (9.8–21.5) 41.5 (32.7–50.2) 27.6 (16.2–38.9) 8.9 (3.6–14.3)
Rich 9.4 (5.9–12.8) 20.7 (14.8–26.6) 42.5 (35.9–49.1) 21.3 (14.5–28.2) 6.1 (2.5–9.6)
Highest educational attainment (%)
None 6.3 (3.6–9.1) 15.6 (10.2–21.0) 41.4 (33.8–49.1) 27.6 (19.1–36.1) 9.0 (4.1–13.8)
Some primary 6.2 (4.0–8.3) 15.3 (11.4–19.2) 41.2 (34.4–48.1) 28.1 (21.8–34.4) 9.2 (5.6–12.8)
Completed primary 5.3 (3.2–7.5) 13.7 (9.1–18.4) 40.1 (33.32–47.0 30.3 (23.2–37.2) 10.5 (5.9–15.1)
Post-primary 5.7 (3.0–8.3) 14.4 (9.5–19.2) 40.6 (31.5–49.8) 29.4 (19.6–39.1) 10.0 (3.8–16.1)
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with 6–7 ideal CVH metrics was 11-fold higher than
that of their male counterparts (3.42% vs. 0.31%; p <
0.001). A similar trend has also been reported in rural
China [27]. Nonetheless, an increased risk for cardiovas-
cular deaths among women versus men in SSA consist-
ent with our results was also demonstrated in a study by
Mensah et. al., [14]. If this data is corroborated with
prospective data including outcomes, it would argue for
a reconsideration of male sex as a primary risk factor for
MACE in the region.
The sex-based differences in ideal CVH we noted were
driven partially by elevated levels of CRP, which were
present in most women. Systemic inflammation is an im-
portant pathophysiological mechanism underlying CVD,
and increased CRP levels are independently predictive of
MACE in western populations [28]. Systemic inflamma-
tion has complex associations with the AHA metrics.
Smoking, diet and physical activity, for example, are caus-
ally related to inflammation [29–31]. However, the fact
that women in our study and others in Uganda had better
health behaviors and worse inflammatory profiles than the
men, suggests the presence of an alternative mechanism
for increased inflammation in this population.
One possible cause for these differences in systemic
inflammation may be chronic exposure to biomass fuel
combustion. Wood and other solid biomass fuels are the
main energy sources for cooking in many households in
SSA. Cooking in Ugandan villages is generally done by
girls and women, and often in poorly ventilated kitchens
[32]. Thus exposure to polluted indoor air begins in
early life for many women. Biomass gases cause systemic
inflammation and oxidative stress, which may be the
mechanistic pathways involved in CVD development
[33–35]. One study in rural India recently reported
greater prevalence of hypertension among relatively
young, never-smoking housewives who cooked exclu-
sively with biomass compared to age-, sex- and
community-matched peers using alternative energy
sources [36]. This hypothesis remains to be tested in
SSA, where 81% of households use biomass fuels as their
primary energy source [37].
In addition to worse ideal CVH profiles among
women, our findings also indicate a relatively high
prevalence of ideal CVH in rural Uganda compared to
other populations. We estimated that approximately 1 in
5 individuals (22.3%) of our study population had at least
6 AHA standard metrics at ideal level, which is at least
twice as high as the prevalence in other comparably
young populations. For example, Ogunmoroti et. al.
(2015) [38], reported a prevalence of 12% for ideal CVH
(≥6 ideal metrics) in a US-based population with mean
age 43 years. The prevalence was much lower at 0.3% in
an Iranian population with a mean age 41 years [39].
We also found an unexpected relationship between
household wealth and CVD risk profiles. The protective
effect of increasing economic wellbeing on CVD risk is
Table 7 Adjusted probability of ideal cardiovascular health behaviors by demographic and socio-economic characteristics
Adjusted predicted probability, % (95% CI)
Number of ideal cardiovascular health behaviors
0 1 2 3
Mean overall probability 4.3 (2.7–5.8) 31.6 (25.3–37.9) 52.7 (45.3–60.1) 11.4 (8.0–14.9)
Sex
Female 2.6 (1.4–3.9) 42.3 (34.2–50.4) 56.5 (48.7–64.3) 18.0 (12.8–23.2)
Male 7.2 (4.4–10.0) 22.8 (15.7–30.0) 43.4 (35.3–51.4) 7.1 (3.9–10.4)
Age group (years)
16–39 2.9 (1.6–4.2) 24.6 (17.3–31.9) 56.0 (48.1–63.8) 16.5 (11.3–21.7)
40–60 5.21 (2.9–7.2) 35.2 (28.2–42.3) 49.7 (42.2–57.1) 10.0 (6.0–14.0)
≥ 60 17.1 (9.6–24.5) 55.1 (47.7–62.5) 25.0 (15.4–34.6) 2.8 (1.0–4.6)
Filmer-Pritchett asset index
Poor 4.1 (2.2–6.0) 31.1 (23.5–38.8) 52.6 (44.8–60.4) 12.1 (7.3–16.9)
Middle 4.0 (2.2–5.8) 30.4 (23.5–37.2) 53.1 (45.1–61.1) 12.6 (8.7–16.4)
Rich 4.8 (2.7–6.8) 34.0 (24.4–43.6) 50.6 (41.5–59.7) 10.6 (6.1–15.0)
Highest educational attainment (%)
None 9.2 (4.3–14.1) 46.9 (36.7–57.1) 38.3 (27.2–49.4) 5.5 (2.1–8.9)
Some primary 4.9 (2.9–7.0) 34.6 (27.8–41.4) 50.1 (42.7–57.5) 10.3 (6.3–14.3)
Completed primary 4.9 (2.5–7.4) 34.6 (25.4–43.9) 50.1 (41.4–58.9) 10.3 (5.4–15.2)
Post-primary 2.9 (1.4–4.4) 24.6 (15.3–33.8) 56.0 (47.7–64.2) 16.6 (10.3–22.8)
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well established in many studies [40, 41]. In contrast, we
found that increasing household wealth was correlated
with worsening ideal CVH health factors. This finding
warrants further exploration [42, 43].
Strengths and limitations
There are a number of limitations to our study. The absence
of longitudinal data on ideal CVH metrics in our study
population prevents us from estimating temporal trends in
CVD risk, and confirming whether CVD risk factors predict
CVH morbidity or mortality. The lack of population-based
cardiovascular outcomes data in Uganda largely precludes
such estimation of the clinical and population health impli-
cations of our findings. As a cross-sectional study, we are
further limited to correlational inferences between ideal
CVH metrics, sex/gender and social determinants. Finally,
our study used definitions of dietary intake and glucose me-
tabolism that differed than those recommended by the
AHA. This should be considered when making direct com-
parisons with other studies of ideal CVH metrics.
Our study also had important strengths. As a relatively
large population-based study, with participants drawn
from a complete census, we were able to make population
level estimates and generalize our results to similar areas
of rural Uganda. Differential participation in the health
fairs was accounted for with the use of IPTW-adjusted
models to derive population-level estimates. We were also
able to include both unique biomedical factors, such as
CRP, and social determinants of health, such as wealth,
education, and sex to contextualize our findings beyond
basic CVD risk estimation.
Conclusions
In this analysis, we present one of the first reports of
AHA ideal CVH metrics from SSA. We demonstrated
that women had worse CVH factors, despite having bet-
ter CVH behaviors than men, and that age, wealth, and
education all contribute to CVD risk in this setting. Our
findings highlight additional areas to be prioritized for
further study, including the downstream repercussions
of these relationships between sex and ideal CVH pro-
files, and the potential role of behavioral exposures, such
as biomass fuel, as sex-specific CVD risk factors.
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